{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:04:52Z","timestamp":1789524292322,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ek0109549s3102"],"award-info":[{"award-number":["JP22ek0109549s3102"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genome Var"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report a Japanese patient with tall stature, dolichocephaly, prominent forehead, narrow nasal ridge, mild retrognathia, subcutaneous fat reduction, bilateral entropion of both eyelids, high arched palate, long fingers, and mild hyperextensible finger joints as a case of Marfanoid-progeroid-lipodystrophy syndrome. Genetic investigation revealed a heterozygous variant NC_000015.10(NM_000138.5):c.8226+5G&gt;A in the <jats:italic>FBN1<\/jats:italic> gene. Skipping of exon 65 and escaping nonsense-mediated decay followed by frameshift were experimentally confirmed in the proband\u2019s mRNA.<\/jats:p>","DOI":"10.1038\/s41439-023-00255-8","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T09:04:41Z","timestamp":1697447081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A case of Marfanoid-progeroid-lipodystrophy syndrome: experimental proof of skipping exons and escaping nonsense-mediated decay"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-8204","authenticated-orcid":false,"given":"Takahito","family":"Moriwaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Masuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0307-238X","authenticated-orcid":false,"given":"Yasuki","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Tawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8490-7299","authenticated-orcid":false,"given":"Takanobu","family":"Otomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"255_CR1","unstructured":"Online Mendelian Inheritance in Man. # 616914 MARFANOID-PROGEROID-LIPODYSTROPHY SYNDROME; MFLS (2019). https:\/\/omim.org\/entry\/616914. Accessed 29 April 2023."},{"key":"255_CR2","unstructured":"GeneReviews\u00ae [Internet]. FBN1-Related Marfan Syndrome (2022). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1335\/ Accessed 29 April 2023."},{"key":"255_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/ejhg.2016.6","volume":"24","author":"E Passarge","year":"2016","unstructured":"Passarge, E., Robinson, P. N. & Graul-Neumann, L. M. Marfanoid-progeroid-lipodystrophy syndrome: a newly recognized fibrillinopathy. Eur. J. Hum. Genet. 24, 1244\u20131247 (2016).","journal-title":"Eur. J. Hum. Genet."},{"key":"255_CR4","unstructured":"Online Mendelian Inheritance in Man. # 154700 MARFAN SYNDROME; MFS (2022). https:\/\/omim.org\/entry\/154700 Accessed 29 April 2023."},{"key":"255_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere, C. et al. Asprosin, a Fasting-Induced Glucogenic Protein Hormone. Cell 165, 566\u2013579. (2016).","journal-title":"Cell"},{"key":"255_CR6","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/nm.4432","volume":"23","author":"C Duerrschmid","year":"2017","unstructured":"Duerrschmid, C. et al. Asprosin is a centrally acting orexigenic hormone. Nat. Med. 23, 1444\u20131453 (2017).","journal-title":"Nat. Med."},{"key":"255_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jmg.2009.072785","volume":"47","author":"BL Loeys","year":"2010","unstructured":"Loeys, B. L. et al. The revised Ghent nosology for the Marfan syndrome. J. Med. Genet. 47, 476\u2013485 (2010).","journal-title":"J. Med. Genet."},{"key":"255_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s10038-022-01025-0","volume":"67","author":"Y Takahashi","year":"2022","unstructured":"Takahashi, Y. et al. Six years\u2019 accomplishment of the Initiative on Rare and Undiagnosed Diseases: nationwide project in Japan to discover causes, mechanisms, and cures. J. Hum. Genet. 67, 505\u2013513 (2022).","journal-title":"J. Hum. Genet."},{"key":"255_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41439-022-00203-y","volume":"9","author":"V Sofronova","year":"2022","unstructured":"Sofronova, V. et al. A novel nonsense variant in ARID1B causing simultaneous RNA decay and exon skipping is associated with Coffin-Siris syndrome. Hum. Genome Var. 9, 26 (2022).","journal-title":"Hum. Genome Var."},{"key":"255_CR10","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1002\/ajmg.a.33690","volume":"11","author":"LM Graul-Neumann","year":"2010","unstructured":"Graul-Neumann, L. M. et al. Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3\u2019 terminus of the FBN1-gene. Am. J. Med. Genet. A 11, 2749\u20132755 (2010).","journal-title":"Am. J. Med. Genet. A"},{"key":"255_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ajmg.a.33906","volume":"155A","author":"J Goldblatt","year":"2011","unstructured":"Goldblatt, J., Hyatt, J., Edwards, C. & Walpole, I. Further evidence for a Marfanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3\u2019 end of the FBN1 gene. Am. J. Med. Genet. A 155A, 717\u2013720 (2011).","journal-title":"Am. J. Med. Genet. A"},{"key":"255_CR12","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ajmg.a.33905","volume":"155A","author":"D Horn","year":"2011","unstructured":"Horn, D. & Robinson, P. N. Progeroid facial features and lipodystrophy associated with a novel splice site mutation in the final intron of the FBN1 gene. Am. J. Med. Genet. A 155A, 721\u2013724 (2011).","journal-title":"Am. J. Med. Genet. A"},{"key":"255_CR13","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1002\/ajmg.a.36157","volume":"161A","author":"T Takenouchi","year":"2013","unstructured":"Takenouchi, T. et al. Severe congenital lipodystrophy and a progeroid appearance: Mutation in the penultimate exon of FBN1 causing a recognizable phenotype. Am. J. Med. Genet. A 161A, 3057\u20133062 (2013).","journal-title":"Am. J. Med. Genet. A"},{"key":"255_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejmg.2014.02.012","volume":"57","author":"A Jacquinet","year":"2014","unstructured":"Jacquinet, A. et al. Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3\u2019 end of FBN1 gene. Eur. J. Med. Genet. 57, 230\u2013234 (2014).","journal-title":"Eur. J. Med. Genet."},{"key":"255_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/ajmg.a.36449","volume":"164A","author":"A Garg","year":"2014","unstructured":"Garg, A. & Xing, C. De novo heterozygous FBN1 mutations in the extreme C-terminal region cause progeroid fibrillinopathy. Am. J. Med. Genet. A 164A, 1341\u20131345 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"255_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1023","author":"M Lin","year":"2019","unstructured":"Lin, M. et al. Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1. Mol. Genet. Genom. Med. https:\/\/doi.org\/10.1002\/mgg3.1023 (2019).","journal-title":"Mol. Genet. Genom. Med."},{"key":"255_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/jmedgenet-2016-104215","volume":"54","author":"KA Miller","year":"2017","unstructured":"Miller, K. A. et al. Diagnostic value of exome and whole genome sequencing in craniosynostosis. J. Med. Genet. 54, 260\u2013268 (2017).","journal-title":"J. Med. Genet."},{"key":"255_CR18","unstructured":"Kempers M., Salemink S., Spruijt L., Marcelis C. & Loeys B. Unusual presentations of thoracic aortic aneurysm in children. Presented at the 13th the Fourth Cardiff Cardiovascular Genetics Symposium \u201cCurrent trends in diagnosis and therapies\u201d, Cardiff, UK, 21-22 November 2013."}],"container-title":["Human Genome Variation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41439-023-00255-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-023-00255-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-023-00255-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T11:08:32Z","timestamp":1704884912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41439-023-00255-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1038\/s41439-023-00255-8","relation":{},"ISSN":["2054-345X"],"issn-type":[{"value":"2054-345X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The multicenter research project Initiative on Rare and Undiagnosed Diseases (IRUD)<sup>7<\/sup> was approved by a central ethics committee at Tohoku University (No. 2017-2-303). Written informed consent was obtained for all genetic tests and publication of the case report with any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"27"}}